TPST
Tempest Therapeutics, Inc.Company with tickers: TPST
CIK
1544227
CUSIP
87978U207
Shares Outstanding
14,806,997
Website
https://www.tempesttx.com
13F Activity (30d)
2 filings
1 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| William Drake Richey | Class II director | Appointed | 2026-06-04 |
| John David Yee | Class II director | Appointed | 2026-06-04 |
| Ms. Simantov | Board of Directors | Resigned | 2026-05-29 |
| Christine Pellizzari | Board of Directors | Resigned | 2026-05-22 |
| Michael Raab | Board of Directors | Resigned | 2026-05-22 |
| Stephen Brady | Board of Directors | Resigned | 2026-05-22 |